News
Common viral infections such as flu, HIV, hepatitis C and shingles can increase the risk of stroke and heart disease, according to a large review of 155 studies. The meta-analysis found that people who caught flu were up to six times more likely to have a heart attack in the month after infection, while those [...]
An international research team has identified a previously unknown genetic disease that affects movement and muscle control. The disease — called Mutation in NAMPT Axonopathy (MINA) syndrome — causes damage to motor neurons, the nerve cells that send signals from the brain and spinal cord to muscles. It’s the result of a rare genetic mutation [...]
A smartphone platform that helps doctors monitor Parkinson’s symptoms has raised US$5.6m to expand its commercial capacity and advance dementia-monitoring technology. The funding brings total investment to US$11.2m for the clinically validated system, which uses smartphones to track changes in movement, speech and cognition. Kneu Health’s platform includes a tremor measurement tool cleared by the [...]
NR Times is excited to reveal the shortist for this year's Charity of the Year Award. The award celebrates charities whose interventions are so critical to the lives of those living with neurological illness or injury, working in innovative and proactive ways to sustain and grow the organisation, while putting service users at the heart [...]
People with both gum disease and cavities face an 86 per cent higher risk of stroke compared with those with healthy mouths, a long-term study has found. The research, which tracked nearly 6,000 adults over 20 years, also linked poor oral health to a 36 per cent greater likelihood of heart attacks and other cardiovascular [...]
A biology teacher has become the first UK patient to receive CAR T-cell therapy for multiple sclerosis (MS) as part of a global clinical trial. Emily Henders, 37, received the treatment at University College London Hospital last week after being diagnosed with MS on Christmas Eve 2021. CAR T-cell therapy is tailored for each patient [...]
ONWARD Medical has raised €50.85m to advance spinal cord stimulation technologies and expand commercialisation of its movement restoration systems. The funding comes from a private placement of 11.3 million new shares at €4.50 per share, extending the company’s cash runway through at least the end of 2026. The Netherlands-based neurotechnology company, which also operates a [...]
A US$3m grant has been awarded to develop a military-optimised ultrasound guidance system for spinal interventions in armed forces medical settings. The funding will support the creation of a portable device designed for epidural steroid injections at forward-deployed military hospitals, with development expected to take 36 months. Medical technology developer RIVANNA received the Peer-Reviewed Medical [...]
NR Times is delighted to announce the shortlist for this year's Brain and Spinal Law Firm of the Year award. The award, sponsored by NCM UK, is one of nine honours being competed for at the third annual NR Times Awards, with winners to be announced on November 19. After careful consideration of numerous exceptional [...]
BioNxt has launched a 15-day dosing optimisation study for its sublingual multiple sclerosis (MS) drug, marking the final step before human bioequivalence testing planned for early 2026. The study represents the last preclinical stage for BNT23001, a thin-film formulation of cladribine designed to dissolve under the tongue for treating MS. Following successful small-animal trials confirming [...]
